Affiliate Program By Category Headlines
NETexponent Wins Dick's Sporting Goods Affiliate Marketing Business
Search and Affiliate Marketing Agency Will Manage Affiliate Program for the Premiere Sporting Goods Retailer.
Read more...
Dispensary Of Hope Welcomes Sanofi-Aventis U.S. As Latest Participant In The Continued Access Program
The Dispensary of Hope is pleased to announce that sanofi-aventis U.S., the U.S. affiliate of sanofi-aventis, a leading global pharmaceutical company, has become the latest pharmaceutical company to participate in the Dispensary's Continued Access Program, which provides uninsured patients with access to medicines that they otherwise couldn't afford. As part of the Continued Access Program ...
Read more...
Microsoft Becomes InCommon Affiliate
ANN ARBOR, Mich. and REDMOND, Wash., July 28 /PRNewswire/ -- Microsoft Corp., a worldwide leader in software, services and solutions, has become an InCommon Affiliate. InCommon is the U.S. trust federation in higher education operated by Internet2. Through InCommon, higher education institutions and their partners offer access to contracted and collaborative services - in a privacy- and security ...
Read more...
Fitch Affirms Colgate Palmolive's 'AA-' Ratings; Outlook Stable
NEW YORK--(BUSINESS WIRE)--Fitch Ratings has affirmed Colgate-Palmolive Company's (Colgate) ratings as follows: --Long-term Issuer Default Rating (IDR) at 'AA-'; --Short-term IDR at 'F1+'; --Senior Unsecured Notes at 'AA-'; --Revolving Credit Facility at 'AA-'; --Commercial Paper Program at 'F1+'. The Rating Outlook is Stable. Approximately $2.5 billion of debt is affected by these actions. The ...
Read more...
FDA Grants Priority Review To Cladribine Tablets For The Treatment Of Relapsing Forms Of MS
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for Cladribine Tablets as a therapy for relapsing forms of multiple sclerosis (MS). The application also has been granted a Priority Review designation by the FDA, which means the review period for the NDA is reduced. The ...
Read more...
|